Pradžia › Glioma
Glioma klinikiniai tyrimai JAV ieško dalyvių
118 tyrimai dėl Glioma ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- New York City, NY25 tyrimai
- Houston, TX23 tyrimai
- Boston, MA20 tyrimai
- Washington, DC19 tyrimai
- Philadelphia, PA16 tyrimai
- Columbus, OH15 tyrimai
- Miami, FL15 tyrimai
- San Francisco, CA14 tyrimai
- Chicago, IL13 tyrimai
- Durham, NC12 tyrimai
- Seattle, WA11 tyrimai
- Los Angeles, CA10 tyrimai
- St. Louis, MO10 tyrimai
- Aurora, CO10 tyrimai
- Rochester, MN9 tyrimai
- Cincinnati, OH9 tyrimai
- Atlanta, GA7 tyrimai
- Edison, NJ7 tyrimai
- Queens, NY7 tyrimai
- Jacksonville, FL6 tyrimai
- Birmingham, AL6 tyrimai
- Omaha, NE6 tyrimai
- San Diego, CA6 tyrimai
- Baltimore, MD6 tyrimai
- Dallas, TX6 tyrimai
- Orange, CA6 tyrimai
- Nashville, TN6 tyrimai
- Cleveland, OH5 tyrimai
- Ann Arbor, MI5 tyrimai
- San Antonio, TX5 tyrimai
- New Rochelle, NY5 tyrimai
- Mountain View, CA4 tyrimai
- New Haven, CT4 tyrimai
- Detroit, MI4 tyrimai
- Pittsburgh, PA4 tyrimai
- Salt Lake City, UT4 tyrimai
- Tampa, FL4 tyrimai
- Arlington, VA4 tyrimai
- Indianapolis, IN4 tyrimai
- Greenburgh, NY4 tyrimai
Pagal valstiją
- Ajova3 tyrimai
- Alabama6 tyrimai
- Arizona8 tyrimai
- Arkansas3 tyrimai
- Džordžija7 tyrimai
- Florida23 tyrimai
- Ilinoisas13 tyrimai
- Indianas4 tyrimai
- Kalifornija25 tyrimai
- Koloradas11 tyrimai
- Kolumbijos apskritis14 tyrimai
- Konektikutas6 tyrimai
- Masčusetsas20 tyrimai
- Merilendas11 tyrimai
- Minesota13 tyrimai
- Misūris11 tyrimai
- Mičiganas8 tyrimai
- Nebraska6 tyrimai
- New Jersey10 tyrimai
- New York28 tyrimai
- North Carolina16 tyrimai
- Ohio18 tyrimai
- Pennsylvania19 tyrimai
- Tennessee8 tyrimai
- Texas26 tyrimai
- Utah4 tyrimai
- Virginia5 tyrimai
- Washington11 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
MCT for the Harvard/UCSF ROBIN Center
Renkami dalyviai
Visi amžiai · Visoms lytims · Atnaujinta 2026-10-01 · NCT06000787Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07025226A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Renkami dalyviai1/2 fazė
12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-10-01 · NCT05099003Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT05030298Language Network Prehab Via fMRI Neurofeedback
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07488780Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07326566Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07416188A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Renkami dalyviai1/2 fazė
Iki 25 metų · Visoms lytims · Atnaujinta 2026-09-25 · NCT04094610MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT03896568Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2026-09-22 · NCT05555550ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Renkami dalyviai2 fazė
12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-09-21 · NCT06838676Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT04977375Development of MRF for Characterization of Brain Tumors After Radiotherapy
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-09-15 · NCT06101069A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Renkami dalyviai1 fazė
Amžius nuo 5 iki 18 · Visoms lytims · Atnaujinta 2026-09-15 · NCT06357377MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT04373720A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Renkami dalyviai1 fazė
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT05698524Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT04771806Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Renkami dalyviai1 fazė
36 Months · Visoms lytims · Atnaujinta 2026-09-09 · NCT07076498NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Renkami dalyviai1 fazė
Amžius nuo 3 iki 25 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07664176Targeted Pediatric High-Grade Glioma Therapy
Renkami dalyviaiStebimasis tyrimas
12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-09-08 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Renkami dalyviai1 fazė
36 Months – 22 Years · Visoms lytims · Atnaujinta 2026-09-04 · NCT03911388A Study of Mirdametinib in People With Central Nervous System Tumors
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07539441Assessing Brain Metabolism Using MRS With Deuterated Glucose
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT06594315Study of Olutasidenib and Temozolomide in HGG
Renkami dalyviai2 fazė
Amžius nuo 12 iki 39 · Visoms lytims · Atnaujinta 2026-09-01 · NCT06161974Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT05489783Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.